Ledger.Open graph →
SEC Form D · filed June 23, 2011

Ultragenyx Pharmaceutical Inc

Offering
$48.7M
Sold
$18.7M
Exemption
—
Industry
Biotechnology
Location
NOVATO, CA
Type
—

People & firms on this filing (9)

Eran Nadav · San Francisco, CADirectorBen Auspitz · Cambridge, MADirectorEmil D. Kakkis · Novato, CAExec · DirectorMarten Steen · Lausanne, V8DirectorKenneth B. Mcelroy · SCOTTSDALE, AZExec · DirectorPharmacy Portfolio Iii, L.L.C · Oak Brook, ILDirectorPharmacy Portfolio III Exchange, L.L.C · Oak Brook, ILDirectorThomas A. Lewis · Mesquite, TXDirectorWilliam Aliski · Novato, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗